Tuesday, August 02, 2022 11:57:13 PM
Charles Cotropia, the company CEO, said, "We are very confident in our Artificial Intelligence empowered Intellectual Patent Portfolio. It has allowed us to claim exclusive rights on an international stage covering critical target sites on numerous human and animal viruses. This places our relatively small company on an equal level with the largest biotech companies in that we are the first to identify and patent critical sites on these many human and animal viruses. This same technology and strategy is being implemented by the Company continuously on new viruses, human or animal. We note that we have identified the conserved sites on the Monkeypox Virus even before the World Health Organization declared it a global health emergency last week.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM